Combigan 2 mg/ml + 5 mg/ml Ophthalmic solution
PDF Leaflet Revision Date: 17 February 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Control of intraocular pressure in chronic open-angle glaucoma or ocular hypertension.
Dosage (summary)
One drop in affected eye(s) twice daily, 12 hours apart.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding.
Key Drug Interactions
- MAO inhibitors
- CNS depressants
- Beta-blockers
Contraindications
- Hypersensitivity
- Reactive airway disease
- Severe cardiac conditions
- Patients under 18 years
Common side effects
- Conjunctival hyperaemia
- Burning sensation
- Bradycardia
- Somnolence
Counselling Points
- Avoid contact with the eye tip
- Remove contact lenses before use
- Monitor for allergic reactions
Serious warnings
- Respiratory and cardiac reactions
- Caution in patients with asthma
- Potential for systemic absorption
Important Disclaimer
The Combigan 2 mg/ml + 5 mg/ml Ophthalmic solution professional information leaflet below is the property of AbbVie and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
